The XX Brain

The instant New York Times bestseller! "In The XX Brain, Lisa meticulously guides us in the ways we can both nourish and protect ourselves, body and mind, to ensure our brains remain resilient throughout our lives." --from the foreword by Maria Shriver The first book to address cognitive enhancement and Alzheimer's prevention specifically in women--and to frame brain health as an essential component of Women's Health. In this revolutionary book, Dr. Lisa Mosconi, director of the Women's Brain Initiative at Weill Cornell Medical College, provides women with the first plan to address the unique risks of the female brain. Until now, medical research has focused on "bikini medicine," assuming that women are essentially men with breasts and tubes. Yet women are far more likely than men to suffer from anxiety, depression, migraines, brain injuries, and strokes. They are also twice as likely to end their lives suffering from Alzheimer's disease, even when their longer lifespans are taken into account. But in the past, the female brain has received astonishingly little attention and was rarely studied by medical researchers-- resulting in a wealth of misinformation about women's health. The XX Brain confronts this crisis by revealing how the two powerful X chromosomes that distinguish women from men impact the brain first and foremost and by focusing on a key brain-protective hormone: estrogen. Taking on all aspects of women's health, including brain fog, memory lapses, depression, stress, insomnia, hormonal imbalances, and the increased risk of dementia, Dr. Mosconi introduces cutting-edge, evidence-based approaches to protecting the female brain, including a specific diet proven to work for women, strategies to reduce stress, and useful tips for restorative sleep. She also examines the controversy about soy and hormonal replacement therapy, takes on the perils of environmental toxins, and examines the role of our microbiome. Perhaps best of all, she makes clear that it is never too late to take care of yourself. The XX Brain is a rallying cry for women to have full access to information regarding what is going on in their brains and bodies as well as a roadmap for the path to optimal, lifelong brain health.

Produk Detail:

  • Author : Lisa Mosconi PhD
  • Publisher : Penguin
  • Pages : 368 pages
  • ISBN : 0593083113
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKThe XX Brain

The XX Brain

The XX Brain
  • Author : Lisa Mosconi PhD
  • Publisher : Penguin
  • Release : 10 March 2020
GET THIS BOOKThe XX Brain

The instant New York Times bestseller! "In The XX Brain, Lisa meticulously guides us in the ways we can both nourish and protect ourselves, body and mind, to ensure our brains remain resilient throughout our lives." --from the foreword by Maria Shriver The first book to address cognitive enhancement and Alzheimer's prevention specifically in women--and to frame brain health as an essential component of Women's Health. In this revolutionary book, Dr. Lisa Mosconi, director of the Women's Brain Initiative at

Alzheimer's Disease Drug Development

Alzheimer's Disease Drug Development
  • Author : Jeffrey L. Cummings,Jefferson W. Kinney,Howard Fillit
  • Publisher : Unknown Publisher
  • Release : 09 December 2021
GET THIS BOOKAlzheimer's Disease Drug Development

"Alzheimer's Disease Drug Development: A Research and Development Ecosystem captures the complexity of Alzheimer's disease (AD) drug develop and provides a comprehensive set of perspectives from the many stakeholders involved in discovering and developing new therapies for AD. There is no greater unmet therapeutic need for humanity than effective therapies for brain disorders. The suffering caused by these conditions and other neurodegenerative disorders is overwhelming and is burdened with substantial stigma. Therefore, I have devoted my professional life to changing

Global Clinical Trials for Alzheimer’s Disease

Global Clinical Trials for Alzheimer’s Disease
  • Author : Roy W. Jones
  • Publisher : Elsevier Inc. Chapters
  • Release : 28 August 2013
GET THIS BOOKGlobal Clinical Trials for Alzheimer’s Disease

Current drug treatments for Alzheimer’s disease (AD) appear to be symptomatic. There is an increasing priority to find effective and safe disease-modifying and preventive treatment strategies for cognitive decline, AD, and dementia. Recent developments have allowed the identification of possible pathogenic processes and pathways, and potential targets for intervention. Cerebrospinal fluid (CSF) biomarkers of ß-amyloid and tau, and neuroimaging including amyloid PET tracer retention show that the pathogenic process begins many years before symptoms appear. A number of preventive

Alzheimer's in America

Alzheimer's in America
  • Author : Anonim
  • Publisher : Unknown Publisher
  • Release : 09 December 2021
GET THIS BOOKAlzheimer's in America

Offers the latest research about the disease, proposals on ways to support both the patient and caregiver, and essays written by patients, family members, and caregivers about living with the disease.

Metabolic and Bioenergetic Drivers of Neurodegenerative Disease: Treating Neurodegenerative Diseases as Metabolic Diseases

Metabolic and Bioenergetic Drivers of Neurodegenerative Disease: Treating Neurodegenerative Diseases as Metabolic Diseases
  • Author : Anonim
  • Publisher : Academic Press
  • Release : 25 August 2020
GET THIS BOOKMetabolic and Bioenergetic Drivers of Neurodegenerative Disease: Treating Neurodegenerative Diseases as Metabolic Diseases

Metabolic Drivers and Bioenergetic Components of Neurodegenerative Disease reviews how the different aspects of metabolic dysfunction and consequent pathology associated with neurodegenerative diseases, including Alzheimer’s and Parkinson’s, can be targeted by novel treatment approaches. Topics covered include Cellular Senescence in Aging and Age-Related Disorders: Implications for Neurodegenerative Diseases; Repurposing GLP1 agonists for Neurodegenerative Diseases; Ketotherapeutics for Neurodegenerative Diseases; Enhancing Mitophagy as a Therapeutic Approach for Neurodegenerative Diseases; Harnessing Neurogenesis in the Adult Brain – A Role in Type 2 Diabetes

Learning to Speak Alzheimer's

Learning to Speak Alzheimer's
  • Author : Joanne Koenig Coste
  • Publisher : Houghton Mifflin Harcourt
  • Release : 08 September 2004
GET THIS BOOKLearning to Speak Alzheimer's

A guide to more successful communication for the millions of Americans caring for someone with dementia: “Offers a fresh approach and hope.”—NPR Revolutionizing the way we perceive and live with Alzheimer’s, Joanne Koenig Coste offers a practical approach to the emotional well-being of both patients and caregivers that emphasizes relating to patients in their own reality. Her accessible and comprehensive method, which she calls habilitation, works to enhance communication between care partners and patients and has proven successful

The Alzheimer's Disease Challenge

The Alzheimer's Disease Challenge
  • Author : Athanasios Alexiou,Mohammad A. Kamal,Ghulam Md Ashraf
  • Publisher : Frontiers Media SA
  • Release : 04 December 2019
GET THIS BOOKThe Alzheimer's Disease Challenge

Alzheimer’s disease is undoubtedly the major health challenge of our Century with significant social and economic consequences. This Frontiers eBook offers a contribution of 39 innovative papers on the multidimensional and crucial problem of Alzheimer’s disease management and treatment. Several perspectives, research updates, and trials describing methods on potential diagnosis and treatment are presented including biological mechanisms, biomarkers and risk factors for an early and efficient prognosis, diagnosis and prevention. Additionally, while the rapidly increasing Alzheimer’s disease population

The Alzheimer's Solution

The Alzheimer's Solution
  • Author : Dean Sherzai,Ayesha Sherzai
  • Publisher : HarperCollins
  • Release : 12 September 2017
GET THIS BOOKThe Alzheimer's Solution

A revolutionary, proven program for reversing the symptoms of Alzheimer's disease and cognitive decline from award winning neurologists and codirectors of the Brain Health and Alzheimer's Prevention Program at Loma Linda University Medical Center Over 47 million people are currently living with Alzheimer’s disease worldwide. While all other major diseases are in decline, deaths from Alzheimer’s have increased radically. What you or your loved ones don’t yet know is that 90 percent of Alzheimer’s cases can be prevented.

Population Health: Behavioral and Social Science Insights

Population Health: Behavioral and Social Science Insights
  • Author : Robert M. Kaplan,Michael L. Spittel,Daryn H. David
  • Publisher : Government Printing Office
  • Release : 24 July 2015
GET THIS BOOKPopulation Health: Behavioral and Social Science Insights

The purpose of this book is to gain a better understanding of the multitude of factors that determine longer life and improved quality of life in the years a person is alive. While the emphasis is primarily on the social and behavioral determinants that have an effect on the health and well-being of individuals, this publication also addresses quality of life factors and determinants more broadly. Each chapter in this book considers an area of investigation and ends with suggestions

Tau oligomers

Tau oligomers
  • Author : Jesus Avila,Naruhiko Sahara
  • Publisher : Frontiers E-books
  • Release : 18 August 2014
GET THIS BOOKTau oligomers

Neurofibrillary tangles (NFTs) composed of intracellular aggregates of tau protein are a key neuropathological feature of Alzheimer’s Disease (AD) and other neurodegenerative diseases, collectively termed tauopathies. The abundance of NFTs has been reported to correlate positively with the severity of cognitive impairment in AD. However, accumulating evidences derived from studies of experimental models have identified that NFTs themselves may not be neurotoxic. Now, many of tau researchers are seeking a “toxic” form of tau protein. Moreover, it was suggested

How Not to Study a Disease

How Not to Study a Disease
  • Author : Karl Herrup
  • Publisher : MIT Press
  • Release : 05 October 2021
GET THIS BOOKHow Not to Study a Disease

An authority on Alzheimer's disease offers a history of past failures and a roadmap that points us in a new direction in our journey to a cure. For decades, some of our best and brightest medical scientists have dedicated themselves to finding a cure for Alzheimer's disease. What happened? Where is the cure? The biggest breakthroughs occurred twenty-five years ago, with little progress since. In How Not to Study a Disease, neurobiologist Karl Herrup explains why the Alzheimer's discoveries of

Cognitive Aging

Cognitive Aging
  • Author : Institute of Medicine,Board on Health Sciences Policy,Committee on the Public Health Dimensions of Cognitive Aging
  • Publisher : National Academies Press
  • Release : 21 July 2015
GET THIS BOOKCognitive Aging

For most Americans, staying "mentally sharp" as they age is a very high priority. Declines in memory and decision-making abilities may trigger fears of Alzheimer's disease or other neurodegenerative diseases. However, cognitive aging is a natural process that can have both positive and negative effects on cognitive function in older adults - effects that vary widely among individuals. At this point in time, when the older population is rapidly growing in the United States and across the globe, it is

Meeting the Challenge of Caring for Persons Living with Dementia and Their Care Partners and Caregivers

Meeting the Challenge of Caring for Persons Living with Dementia and Their Care Partners and Caregivers
  • Author : National Academies of Sciences Engineering and Medicine,Health and Medicine Division,Board on Health Care Services,Board on Health Sciences Policy,Committee on Care Interventions for Individuals with Dementia and Their Caregivers
  • Publisher : Unknown Publisher
  • Release : 23 November 2021
GET THIS BOOKMeeting the Challenge of Caring for Persons Living with Dementia and Their Care Partners and Caregivers

Early Diagnosis of Alzheimer’s Disease

Early Diagnosis of Alzheimer’s Disease
  • Author : Leonard F. M. Scinto,Kirk R. Daffner
  • Publisher : Springer Science & Business Media
  • Release : 09 February 2000
GET THIS BOOKEarly Diagnosis of Alzheimer’s Disease

Drs. Leonard Scinto and Kirk Daffner provide a comprehensive survey of new diagnostic approaches to Alzheimer's disease. The authoritative contributors critically survey the most promising current research on early diagnostic markers for Alzheimer's disease, including the elucidation of changes in the brain revealed by structural and functional neuroimaging, as well as the characteristic patterns of cognitive decline that are documented by sensitive neuropsychological tests, various genetic markers, and biological assays. Early Diagnosis of Alzheimer's Disease illuminates the complex issues surrounding